Apimeds Pharmaceuticals US (APUS) vs GT Biopharma (GTBP)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
GT Biopharma (GTBP) has outperformed Apimeds Pharmaceuticals US (APUS) over the past year, gaining 724.5% versus a loss of 58.8%. GT Biopharma is the larger company by market cap ($10.8 million vs $8.3 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | APUS | GTBP |
|---|---|---|
| Share price | $5.51 | $5.96 |
| Market cap | $8.32M | $10.75M |
| 1-day change | -21.84% | -3.87% |
| YTD return | -57.01% | +689.81% |
| 1-year return | -58.77% | +724.47% |
| 5-year return | — | -96.58% |
| EPS (TTM) | $-36.03 | $-147.50 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $59.70 | $28.75 |
| 52-week low | $1.51 | $4.91 |
| Distance from 52-week high | -90.77% | -79.27% |
| Average volume | 3.65M | 55.55K |
| Shares outstanding | 1.51M | 1.80M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- GTBP has outperformed APUS by 783.2 percentage points over the past year.
APUS vs GTBP FAQ
Which is bigger, Apimeds Pharmaceuticals US or GT Biopharma?
GT Biopharma (GTBP) is larger, with a market capitalization of $10.75M compared with $8.32M for Apimeds Pharmaceuticals US (APUS).
Which stock has performed better over the past year, APUS or GTBP?
GTBP returned +724.47% over the past 12 months, compared with -58.77% for APUS (price return, excluding dividends). Past performance does not predict future results.
Are Apimeds Pharmaceuticals US and GT Biopharma in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.